Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…

Emerging therapies for Duchenne muscular dystrophy - ScienceDirect

September, 2018

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Therapeutic approaches for Duchenne muscular dystrophy

PDF) Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy

Frontiers Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics

Vascular-targeted therapies for Duchenne muscular dystrophy, Skeletal Muscle

muscle stem cells, The Stem Cellar

New treatment could benefit up to 45 per cent of patients with

Deep dive into muscle repair yields new strategies to combat Duchenne muscular dystrophy

Recent advances in the management of Duchenne muscular dystrophy